WOODCLIFF LAKE, N.J., Oct. 25, 2012 /PRNewswire/ — Par Pharmaceutical Companies, Inc. today announced that its operating subsidiary, Anchen Pharmaceuticals, Inc., has received final approval from the U.S. Food and Drug Administration for its …
Par Pharmaceutical Receives Final Approval To Market Tretinoin Capsules